In conclusion, obesity or overweight, insulin resistance, hyperglycemia, and sarcopenia are common comorbidity of OI children, of which circulating LCN2 deficiency may be closely relevant to these disorders, which indicates that bone may play an important role in regulating glycolipid metabolism and body composition through LCN2. The gene discussed is LCN2; the disease is Insulin resistance.